bioRxivPharmacology & ToxicologyPreprint
Segmented regression to streamline semi-mechanistic pharmacodynamic modelling of antibiotic effects
Anh Duc PhamiD, Wisse van OsiD, Jorn BrinkiD, Johan G.C. van HasseltiD, Linda B.S. AuliniD
Abstract
Purpose Semi-mechanistic pharmacodynamic (PD) models quantify bacterial dynamics from time-kill (TK) assays, often showing multi-phasic kill and regrowth dynamics. Regrowth is typically captured with two subpopulations with distinct concentration-effect relationships. Since only total bacterial counts are observed, subpopulation dynamics must be inferred, causing identifiability issues, sensitivity to initial estimates, and model-testing burden. We aimed to establish an efficient and robust approach for developing semi-mechanistic PD models, demonstrated with 24-hour TK data for colistin against Pseudomonas aeruginosa. Methods A three-step workflow was developed: (1) log-transformed TK data were segmented into kill and regrowth phases, with linear regression estimating phase-specific slopes per concentration and replicate; (2) empirical slopes were pooled to derive concentration-effect relationships; (3) selected relationships and parameter estimates were incorporated into a semi-mechanistic PD model. Results Segmented regression captured kill and regrowth slopes at all concentrations. Slope saturation with increasing colistin and consistently weaker drug effect during regrowth indicated a less susceptible subpopulation, motivating a two-subpopulation model. The semi-mechanistic model adequately described bacterial dynamics at all concentrations, with parameters comparable to Step 2. Conclusion This three-step workflow enables efficient and robust identification of concentration-effect relationships, reducing model testing and computational burden for streamlined semi-mechanistic antibiotic PD model development.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pharmacodynamic modeling of colistin and imipenem against in vitro Pseudomonas aeruginosa biofilms
Yuchen Guo, Jinqiu Yin, … J. G. Coen van Hasselt·BiofilmPeer-reviewed·Aug 3, 2026
- Antibiotic tolerance due to filamentation shapes β-lactam pharmacodynamics in Escherichia coli
Aryan Ramachandran, Josia Pool, … Aditi Batra·bioRxiv·Aug 26, 2026
- Quantifying antibiotic susceptibility and inoculum effects using transient dynamics of Pseudomonas aeruginosa
Sarah A Sundius, Jennifer M. Farrell, … Sam P. Brown·PLoS Computational BiologyPeer-reviewed·Oct 5, 2026
- Replacing In Vivo Experiments for PK/PD Target Determination Through In Vitro Time-Kill Experiments and PK/PD Modelling Incorporating Inter-strain Variability: Application to Meropenem Against Pseudomonas aeruginosa
Julien M. Buyck, Ombeline Krekounian, … Nicolas Grégoire·bioRxiv·Sep 15, 2026
- Pharmacodynamic Considerations of Collateral Sensitivity in Design of Antibiotic Treatment Regimen
K. I. Udekwu, H. Weiss·bioRxiv·May 31, 2018
- Pharmacodynamic model of the dynamic response of Pseudomonas aeruginosa biofilms to drug treatments
S. Roychowdhury, C. M. Roth·bioRxiv·Jul 29, 2022